EXPONENT, INC. Net Change in Cash
EXPONENT, INC. (EXPO) reported Net Change in Cash of -$155.30 million for the 6-month period ending 2026-07-03, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-07
- EXPONENT, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-04-03 was -$103.38M.
- EXPONENT, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-04-04 was -$13.79M.
- EXPONENT, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-29 was -$18.48M.
- EXPONENT, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$35.81M.
- EXPONENT, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2026 was -$36.97M, a 151.53% decline from fiscal 2025.
- EXPONENT, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was $71.75M, a 179.27% increase from fiscal 2023.
- EXPONENT, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $25.69M.
- EXPONENT, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$136.23M, a 236.01% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-07-03 | -$155.30M 10-Q · filed 2026-08-07 | |||
| 2026-04-03 | -$103.38M 10-Q · filed 2026-05-08 | |||
| 2026-01-02 | -$36.97M 10-K · filed 2026-02-27 | |||
| 2025-10-03 | -$51.52M 10-Q · filed 2025-11-07 | |||
| 2025-07-04 | -$27.10M 10-Q · filed 2026-08-07 | |||
| 2025-04-04 | -$13.79M 10-Q · filed 2026-05-08 | |||
| 2025-01-03 | $71.75M 10-K · filed 2026-02-27 | |||
| 2024-09-27 | $32.56M 10-Q · filed 2025-11-07 | |||
| 2024-06-28 | $16.11M 10-Q · filed 2025-08-08 | |||
| 2024-03-29 | -$18.48M 10-Q · filed 2025-05-09 | |||
| 2023-12-29 | $25.69M 10-K · filed 2026-02-27 | |||
| 2023-09-29 | -$24.36M 10-Q · filed 2024-11-01 | |||
| 2023-06-30 | -$13.28M 10-Q · filed 2024-08-02 | |||
| 2023-03-31 | -$35.81M 10-Q · filed 2024-05-03 | |||
| 2022-12-30 | -$136.23M 10-K · filed 2025-02-28 | |||
| 2022-09-30 | -$149.24M 10-Q · filed 2023-11-03 | |||
| 2022-07-01 | -$132.07M 10-Q · filed 2023-08-07 | |||
| 2022-04-01 | -$82.64M 10-Q · filed 2023-05-05 | |||
| 2021-12-31 | $100.16M 10-K · filed 2024-02-23 | |||
| 2021-10-01 | $32.26M 10-Q · filed 2022-11-04 | |||
| 2021-07-02 | $42.43M 10-Q · filed 2022-08-05 | |||
| 2021-04-02 | -$13.00M 10-Q · filed 2021-05-07 | |||
| 2021-01-01 | $21.09M 10-K · filed 2023-02-24 | |||
| 2020-10-02 | $11.20M 10-Q · filed 2020-11-06 | |||
| 2020-07-03 | -$20.50M 10-Q · filed 2021-08-06 | |||
| 2020-04-03 | -$70.84M 10-Q · filed 2021-05-07 | |||
| 2020-01-03 | $49.38M 10-K · filed 2022-02-25 | |||
| 2019-09-27 | $5.78M 10-Q · filed 2020-11-06 | |||
| 2019-06-28 | -$22.61M 10-Q · filed 2020-08-07 | |||
| 2019-03-29 | -$47.98M 10-Q · filed 2020-05-08 | |||
| 2018-12-28 | $2.27M 10-K · filed 2021-02-26 | |||
| 2018-09-28 | -$3.82M 10-Q · filed 2019-11-01 | |||
| 2018-06-29 | -$7.02M 10-Q · filed 2019-08-02 | |||
| 2018-03-30 | -$21.64M 10-Q · filed 2019-05-03 | |||
| 2017-12-29 | $9.83M 10-K · filed 2020-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Huron Consulting Group Inc. (HURN) | United States | $2.557B | 20.80 |
| FTI CONSULTING, INC (FCN) | United States | $3.602B | 16.33 |
| Astrana Health, Inc. (ASTH) | United States | $1.921B | 63.77 |
| ICF International, Inc. (ICFI) | United States | $1.490B | 14.74 |
| Bowman Consulting Group Ltd. (BWMN) | United States | $0.738B | 68.09 |
| Onterris, Inc. (ONT) | United States | $0.590B | -63.69 |
| Genpact LTD (G) | $5.608B | 7.94 | |
| Public Policy Holding Company, Inc. (PPHC) | United States | $0.347B | |
| Aeries Technology, Inc. (AERT) | Cayman Islands | $0.336B | -0.00 |
| TSS, Inc. (TSSI) | United States | $0.288B | 24.06 |